Developer docs
API playgroundTry for free, no card

Search company profiles

oloBion

Full company profile

uuid000gw2u

Namestring
oloBion
Legal namestring
oloBion SL
Websiteurl
olobion.ai
Company typeenum
Private
Founded yearint
2020
Descriptiontext

oloBion SL is a Barcelona-based Contract Research Organization founded in 2020 that provides end-to-end mass spectrometry-based multi-omics services, with a satellite laboratory at the UC Davis Genome Center in California and a New York sales office. The company offers metabolomics, lipidomics, proteomics (including Olink PEA-based targeted panels), ADME-DMPK, ionomics, caroteomics, and nutritional analysis across seven application verticals — pharmaceutical and biotechnology, biomedicine and health research, agriculture and food, cosmetics and dermatology, nutraceutical and nutrition, veterinary and animal science, and environmental and ecology.

The technical stack combines high-resolution mass spectrometry platforms (Agilent 6560 Ion Mobility Q-TOF, SCIEX ZenoTOF 7600 with Electron-Activated Dissociation, Agilent 7200 GC-MS, Agilent 1260 UPLC, Agilent 4210 MP-AES, LECO CN 8028) with the proprietary AI-powered bioinformatics platform oloMAP, backed by a database of more than one million biomolecules. oloMAP's 4D-ID® strategy uses machine learning to combine accurate mass, MS/MS fragmentation, retention time, and collision cross section for high-confidence lipid identification, and is delivered to clients through the oloMAP Portal web application for interactive data analysis and biological interpretation. The portal has received continuous feature updates from its 2024 launch through 2026, including pathway analysis, advanced statistics, and N-omics integration.

oloBion generates revenue through project-based analytical service contracts on a quote-based model with volume and multi-omics bundle discounts, alongside a 6-week standard delivery and fast-track option. The oloMAP Portal and Biological Interpretation Report function as premium add-ons that introduce subscription-like recurring revenue characteristics. The company serves more than 1,000 researchers in academia and industry worldwide, and supplements service revenue with non-dilutive grant funding from Eurostars programmes (LIPIDOMAB 2023-2025, NEUROSPARK €2.3M, 2026), CDTI, EU Horizon Europe, and the Spanish Pyme Innovadora certification. Quality systems are certified to ISO 9001:2015 and UNE-EN ISO/IEC 17025:2017 with Good Laboratory Practice compliance. The company is founder-controlled, with no disclosed institutional equity capital.

Short descriptiontext

oloBion is a Barcelona-based CRO providing end-to-end mass spectrometry-based metabolomics, lipidomics, and proteomics services to over 1,000 researchers across pharma, biotech, academia, and seven life-science application verticals, supported by its proprietary AI-powered oloMAP bioinformatics platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
omics analytical services, mass spectrometry workflows, metabolomics lipidomics proteomics, contract research organization, bioinformatics data interpretation
Industry1 code
PRIMARYHLAGANAG
Metabolomics & Lipidomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (Omics Analytical Services)
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Omics Analytical Services (CRO)
TypeProfessional Services
Description

oloBion operates as a science-based Contract Research Organization (CRO) providing end-to-end mass spectrometry-based omics analytical services. Services include metabolomics, lipidomics, proteomics, ADME-DMPK, bioinformatics (oloMAP), Olink proteomics, ionomics, caroteomics, and nutritional analysis. Revenue is generated through project-based analytical service contracts with academic and industry clients. Pricing includes discounts associated with number of samples and multi-omics analysis, with standard 6-week delivery and fast-track options.

olobion.ai
2Bioinformatics Software Services (oloMAP Portal)
TypeSubscription Recurring
Description

oloMAP Portal provides bioinformatics data analysis and interpretation as part of the integrated omics service offering. The platform offers single-omics and multi-omics analyses with Advanced Statistics and Biological Interpretation Reports as premium add-ons, supporting the core analytical service revenue stream.

olobion.ai
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based analytical services with volume and multi-omics discounts
ModelOtherBilling cadenceMulti-year contract
Notes

Contact-based pricing. Discounts associated with number of samples and multi-omics analysis. Standard delivery time of 6 weeks with fast-track option available.

olobion.ai
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1oloMAP
Description

AI-powered bioinformatics platform for omics data processing, annotation, and visualization

olobion.ai
+2 more records
Core offering1 text field

oloBion is a science-based Contract Research Organization (CRO) providing end-to-end mass spectrometry-based omics analytical services, including metabolomics, lipidomics, proteomics, ADME-DMPK, ionomics, caroteomics, and nutritional analysis. Sample preparation through biological interpretation is delivered as an integrated service, powered by the proprietary AI-driven oloMAP bioinformatics platform and a database of over one million biomolecules. The company serves academic and industry clients across seven application verticals from its laboratories in Barcelona (Spain) and at UC Davis (USA).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Standard delivery time of 6 weeks with fast-track option available, enabling predictable research timelines
+2 more records
Product overview1 text field

oloBion is a science-based CRO (Contract Research Organization) providing end-to-end mass spectrometry–based omics services, including metabolomics, lipidomics, proteomics, ADME–DMPK, ionomics, caroteomics, and nutritional analysis. The offering is organized as a multi-layered portfolio: at the core is the proprietary AI-powered bioinformatics platform oloMAP, which powers all data processing and biomolecule identification using a database of over 1 million biomolecules, and its web-based interface oloMAP Portal for interactive data analysis, visualization, and biological interpretation. oloMAP Portal supports both single-omics and multi-omics integration workflows. The analytical infrastructure is anchored by advanced mass spectrometry platforms — the Agilent 6560 Ion Mobility Q-TOF LC/MS (metabolomics), SCIEX ZenoTOF 7600 with EAD technology (lipidomics/proteomics), Agilent 7200 GC-MS, Agilent 4210 MP-AES, Agilent 1260 UPLC, and LECO CN 8028 — complemented by Olink® PEA-based targeted proteomics as an authorized service provider. oloBion also offers specialized ADME–DMPK services and a Biological Interpretation Report add-on. Services span seven application verticals: Pharmaceutical & Biotechnology, Biomedicine & Health Research, Agriculture & Food, Cosmetics & Dermatology, Nutraceutical & Nutrition, Veterinary & Animal Science, and Environmental & Ecology. The company is ISO 9001:2015 certified and participates in funded research projects including LIPIDOMAB (Eurostars) and NEUROSPARK (Eurostars).

Product and service3 records
1oloMAP Bioinformatics Platform
CategoryBioinformatics software platform
Description

Proprietary AI-powered bioinformatics platform for high-throughput metabolomics, lipidomics and proteomics data processing, high-confidence feature annotation and identification, powered by a proprietary database of over one million biomolecules.

2oloMAP Portal
CategoryBioinformatics software platform
Description

Interactive web-based platform for omics data analysis and interpretation, integrating statistical analysis with data visualization and supporting single-omics, multi-omics, and N-omics integration for in-depth biological exploration.

3Lipidomics Services
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

oloBion is a partner in the NEUROSPARK Eurostars grant project (€2.3M, 36 months) led by InVirtuoLabs, alongside 7hc (Italy) and INSYBIO (Greece). The project aims to identify and validate 3-5 lead small molecules for Spinocerebellar Ataxia Type 3 (SCA3), a rare neurodegenerative movement disorder, using AI-based Virtual Cell Models as digital twins of diseased cells.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

Partner in NEUROSPARK Eurostars grant project for SCA3 drug discovery using AI-based Virtual Cell Models. oloBion provides omics analytical capabilities as part of the multi-partner consortium.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

Partner in NEUROSPARK Eurostars grant project for SCA3 drug discovery using AI-based Virtual Cell Models. oloBion provides omics analytical capabilities as part of the multi-partner consortium.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-25
Description

oloBion and IRB Barcelona entered into a collaboration agreement for advanced metabolomic, proteomic and lipidomic analyses on murine and human tissue and biological fluid samples. The partnership supports the Stem Cell and Cancer laboratory led by Dr. Salvador Aznar Benitah, focusing on metabolic alterations in cancer models (oral squamous cell carcinoma, triple-negative breast cancer) and metabolically relevant tissues (liver, muscle, adipose tissue). IRB Barcelona gains access to high-quality omics datasets for biological understanding and molecular signature identification.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

oloBion is part of the Nutrialitec consortium, co-funded by CDTI and NextGeneration EU (Plan de Recuperación, Transformación y Resiliencia). Partners include Centro Tecnológico Nacional de la Conserva y Alimentación (CTNC), CTAEX, Basque Culinary Center Innovation, UCAM, and Artica+i. Focus on food technology and nutrition innovation research.

6LIPIDOMAB Eurostars Project
Strategic tierCoreTypeStrategic or Co-development Partner
Description

oloBion participated in the LIPIDOMAB Eurostars project (CIIP-20232025) focused on accelerating development of a first-in-class antibody blocking lipid metabolism for treatment of advanced cancer through novel breakthrough technologies. Project received co-funding from CDTI and EU Horizon Europe.

olobion.ai
Strategic tierCoreTypeTechnology or Integration
Description

oloBion is an official Olink Certified Service Provider for Olink Target and Olink Flex proteomics products. The company has passed Olink certification testing and integrates Olink proximity extension assay (PEA) technology with its own LC-MS proteomics and multi-omics services for comprehensive proteomics solutions.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Atens is listed as a partner company with which oloBion shares data for marketing purposes under customer consent. Atens develops agricultural biotechnologies and natural agricultural solutions.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Hello-Nature Group is listed as a partner company with which oloBion shares data for marketing purposes under customer consent. Hello-Nature focuses on agricultural and nutritional solutions.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Metabolon is a leading metabolomics CRO offering global Precision Metabolomics profiling services to pharma, biotech, and academic clients. It is the most directly comparable scaled competitor to oloBion in the metabolomics services market.

TypeDirect peer
Description

Creative Proteomics offers metabolomics, lipidomics, and proteomics services to academic and industry researchers globally. Directly comparable as a multi-omics CRO competing for similar project-based engagements.

TypeDirect peer
Description

Biocrates provides standardized metabolomics and lipidomics kits and CRO services focused on quantitative targeted metabolomics. Comparable to oloBion as a specialized metabolomics/lipidomics service provider with proprietary assay panels.

TypeBroad incumbent
Description

Evotec is a global drug discovery CRO with multi-omics, biomarker, and DMPK capabilities. Comparable as a broad incumbent competing for outsourced discovery budgets that oloBion serves in pharma/biotech.

TypeBroad incumbent
Description

Eurofins Discovery is a large, diversified CRO offering ADME-DMPK, metabolomics, and biomarker services through its Discovery and Pharma Discovery franchises. Comparable to oloBion on ADME-DMPK and analytical services, but with far broader portfolio and scale.

TypeBroad incumbent
Description

Bruker is a leading mass spectrometry and NMR instrumentation vendor offering timsTOF-based 4D-omics solutions and increasingly services/applications support. Comparable as a technology incumbent in ion-mobility-based omics that competes at the platform level.

TypeBroad incumbent
Description

Olink provides proximity extension assay (PEA) proteomics technology and a network of certified service providers. Comparable as the technology incumbent behind the proteomics platform oloBion offers as a Certified Service Provider.

TypeBroad incumbent
Description

Charles River is a global CRO with discovery, safety assessment, and manufacturing services including preclinical DMPK capabilities. Comparable as a broad incumbent that competes for preclinical ADME-DMPK and discovery budgets.

TypeDirect peer
Description

Lipotype is a lipidomics-focused CRO providing mass spectrometry-based lipid analysis for academic and industry clients. Directly comparable to oloBion's lipidomics specialization and 4D-ID®-style structural characterization.

10West Coast Metabolomics Center (UC Davis)
TypeRegional player
Description

WCMC is an NIH-funded metabolomics core at UC Davis directed by Oliver Fiehn (oloBion's Metabolomics Advisor). It is co-located with oloBion's Davis lab and overlaps in metabolomics services and training offerings.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers28 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

oloBion

Contract Research Organization (Omics Analytical Services)olobion.ai

oloBion is a Barcelona-based CRO providing end-to-end mass spectrometry-based metabolomics, lipidomics, and proteomics services to over 1,000 researchers across pharma, biotech, academia, and seven life-science application verticals, supported by its proprietary AI-powered oloMAP bioinformatics platform.

What oloBion does

oloBion SL is a Barcelona-based Contract Research Organization founded in 2020 that provides end-to-end mass spectrometry-based multi-omics services, with a satellite laboratory at the UC Davis Genome Center in California and a New York sales office. The company offers metabolomics, lipidomics, proteomics (including Olink PEA-based targeted panels), ADME-DMPK, ionomics, caroteomics, and nutritional analysis across seven application verticals — pharmaceutical and biotechnology, biomedicine and health research, agriculture and food, cosmetics and dermatology, nutraceutical and nutrition, veterinary and animal science, and environmental and ecology.

The technical stack combines high-resolution mass spectrometry platforms (Agilent 6560 Ion Mobility Q-TOF, SCIEX ZenoTOF 7600 with Electron-Activated Dissociation, Agilent 7200 GC-MS, Agilent 1260 UPLC, Agilent 4210 MP-AES, LECO CN 8028) with the proprietary AI-powered bioinformatics platform oloMAP, backed by a database of more than one million biomolecules. oloMAP's 4D-ID® strategy uses machine learning to combine accurate mass, MS/MS fragmentation, retention time, and collision cross section for high-confidence lipid identification, and is delivered to clients through the oloMAP Portal web application for interactive data analysis and biological interpretation. The portal has received continuous feature updates from its 2024 launch through 2026, including pathway analysis, advanced statistics, and N-omics integration.

oloBion generates revenue through project-based analytical service contracts on a quote-based model with volume and multi-omics bundle discounts, alongside a 6-week standard delivery and fast-track option. The oloMAP Portal and Biological Interpretation Report function as premium add-ons that introduce subscription-like recurring revenue characteristics. The company serves more than 1,000 researchers in academia and industry worldwide, and supplements service revenue with non-dilutive grant funding from Eurostars programmes (LIPIDOMAB 2023-2025, NEUROSPARK €2.3M, 2026), CDTI, EU Horizon Europe, and the Spanish Pyme Innovadora certification. Quality systems are certified to ISO 9001:2015 and UNE-EN ISO/IEC 17025:2017 with Good Laboratory Practice compliance. The company is founder-controlled, with no disclosed institutional equity capital.

oloBion firmographics

Firmographics
Name
oloBion
Legal name
oloBion SL
Website
https://olobion.ai
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
oloBion is a Barcelona-based CRO providing end-to-end mass spectrometry-based metabolomics, lipidomics, and proteomics services to over 1,000 researchers across pharma, biotech, academia, and seven life-science application verticals, supported by its proprietary AI-powered oloMAP bioinformatics platform.
Ownership category
akta.pro rank

oloBion industry classification

Industry
Product category
Contract Research Organization (Omics Analytical Services)
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAG
Metabolomics & Lipidomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Omics analytical services
  • Mass spectrometry workflows
  • Metabolomics lipidomics proteomics
  • Contract research organization
  • Bioinformatics data interpretation

Where oloBion is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices3 records

Markets served

oloBion business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Omics Analytical Services (CRO): oloBion operates as a science-based Contract Research Organization (CRO) providing end-to-end mass spectrometry-based omics analytical services. Services include metabolomics, lipidomics, proteomics, ADME-DMPK, bioinformatics (oloMAP), Olink proteomics, ionomics, caroteomics, and nutritional analysis. Revenue is generated through project-based analytical service contracts with academic and industry clients. Pricing includes discounts associated with number of samples and multi-omics analysis, with standard 6-week delivery and fast-track options.
  2. Bioinformatics Software Services (oloMAP Portal): oloMAP Portal provides bioinformatics data analysis and interpretation as part of the integrated omics service offering. The platform offers single-omics and multi-omics analyses with Advanced Statistics and Biological Interpretation Reports as premium add-ons, supporting the core analytical service revenue stream.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based analytical services with volume and multi-omics discounts

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

oloBion product offering

Product offering

Core offering

oloBion is a science-based Contract Research Organization (CRO) providing end-to-end mass spectrometry-based omics analytical services, including metabolomics, lipidomics, proteomics, ADME-DMPK, ionomics, caroteomics, and nutritional analysis. Sample preparation through biological interpretation is delivered as an integrated service, powered by the proprietary AI-driven oloMAP bioinformatics platform and a database of over one million biomolecules. The company serves academic and industry clients across seven application verticals from its laboratories in Barcelona (Spain) and at UC Davis (USA).

Product overview

oloBion is a science-based CRO (Contract Research Organization) providing end-to-end mass spectrometry–based omics services, including metabolomics, lipidomics, proteomics, ADME–DMPK, ionomics, caroteomics, and nutritional analysis. The offering is organized as a multi-layered portfolio: at the core is the proprietary AI-powered bioinformatics platform oloMAP, which powers all data processing and biomolecule identification using a database of over 1 million biomolecules, and its web-based interface oloMAP Portal for interactive data analysis, visualization, and biological interpretation. oloMAP Portal supports both single-omics and multi-omics integration workflows. The analytical infrastructure is anchored by advanced mass spectrometry platforms — the Agilent 6560 Ion Mobility Q-TOF LC/MS (metabolomics), SCIEX ZenoTOF 7600 with EAD technology (lipidomics/proteomics), Agilent 7200 GC-MS, Agilent 4210 MP-AES, Agilent 1260 UPLC, and LECO CN 8028 — complemented by Olink® PEA-based targeted proteomics as an authorized service provider. oloBion also offers specialized ADME–DMPK services and a Biological Interpretation Report add-on. Services span seven application verticals: Pharmaceutical & Biotechnology, Biomedicine & Health Research, Agriculture & Food, Cosmetics & Dermatology, Nutraceutical & Nutrition, Veterinary & Animal Science, and Environmental & Ecology. The company is ISO 9001:2015 certified and participates in funded research projects including LIPIDOMAB (Eurostars) and NEUROSPARK (Eurostars).

Differentiator

Problem solved

Functional benefit

Brands

  • oloMAP: AI-powered bioinformatics platform for omics data processing, annotation, and visualization
  • oloMAP Portal
  • oloMAP 4D-ID®

Products and services

  • oloMAP Bioinformatics Platform Proprietary AI-powered bioinformatics platform for high-throughput metabolomics, lipidomics and proteomics data processing, high-confidence feature annotation and identification, powered by a proprietary database of over one million biomolecules.
  • oloMAP Portal Interactive web-based platform for omics data analysis and interpretation, integrating statistical analysis with data visualization and supporting single-omics, multi-omics, and N-omics integration for in-depth biological exploration.
  • Lipidomics Services

Quantifiable outcome

  • Standard delivery time of 6 weeks with fast-track option available, enabling predictable research timelines
  • +2 more outcomes

Companies that use oloBion

Customer profile

Named customers28 records

Segments7 records

Ideal customer profiles5 records

oloBion technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

oloBion partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • InVirtuoLabscoreStrategic or Co-development Partner · 11 February 2026oloBion is a partner in the NEUROSPARK Eurostars grant project (€2.3M, 36 months) led by InVirtuoLabs, alongside 7hc (Italy) and INSYBIO (Greece). The project aims to identify and validate 3-5 lead small molecules for Spinocerebellar Ataxia Type 3 (SCA3), a rare neurodegenerative movement disorder, using AI-based Virtual Cell Models as digital twins of diseased cells.
  • 7hc (Italy)coreStrategic or Co-development Partner · 11 February 2026Partner in NEUROSPARK Eurostars grant project for SCA3 drug discovery using AI-based Virtual Cell Models. oloBion provides omics analytical capabilities as part of the multi-partner consortium.
  • INSYBIO (Greece)coreStrategic or Co-development Partner · 11 February 2026Partner in NEUROSPARK Eurostars grant project for SCA3 drug discovery using AI-based Virtual Cell Models. oloBion provides omics analytical capabilities as part of the multi-partner consortium.
  • IRB Barcelona (Institute for Research in Biomedicine)coreStrategic or Co-development Partner · 25 March 2025oloBion and IRB Barcelona entered into a collaboration agreement for advanced metabolomic, proteomic and lipidomic analyses on murine and human tissue and biological fluid samples. The partnership supports the Stem Cell and Cancer laboratory led by Dr. Salvador Aznar Benitah, focusing on metabolic alterations in cancer models (oral squamous cell carcinoma, triple-negative breast cancer) and metabolically relevant tissues (liver, muscle, adipose tissue). IRB Barcelona gains access to high-quality omics datasets for biological understanding and molecular signature identification.
  • Nutrialitec ConsortiumcoreStrategic or Co-development PartneroloBion is part of the Nutrialitec consortium, co-funded by CDTI and NextGeneration EU (Plan de Recuperación, Transformación y Resiliencia). Partners include Centro Tecnológico Nacional de la Conserva y Alimentación (CTNC), CTAEX, Basque Culinary Center Innovation, UCAM, and Artica+i. Focus on food technology and nutrition innovation research.
  • LIPIDOMAB Eurostars ProjectcoreStrategic or Co-development PartneroloBion participated in the LIPIDOMAB Eurostars project (CIIP-20232025) focused on accelerating development of a first-in-class antibody blocking lipid metabolism for treatment of advanced cancer through novel breakthrough technologies. Project received co-funding from CDTI and EU Horizon Europe.
  • OlinkcoreTechnology or IntegrationoloBion is an official Olink Certified Service Provider for Olink Target and Olink Flex proteomics products. The company has passed Olink certification testing and integrates Olink proximity extension assay (PEA) technology with its own LC-MS proteomics and multi-omics services for comprehensive proteomics solutions.
  • Atens (Agrotecnologias Naturales SL)minorGTM or Marketing PartnerAtens is listed as a partner company with which oloBion shares data for marketing purposes under customer consent. Atens develops agricultural biotechnologies and natural agricultural solutions.
  • Hello-Nature GroupminorGTM or Marketing PartnerHello-Nature Group is listed as a partner company with which oloBion shares data for marketing purposes under customer consent. Hello-Nature focuses on agricultural and nutritional solutions.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

oloBion competitors and assessment

Company assessment

Direct peers

  • Metabolon: Metabolon is a leading metabolomics CRO offering global Precision Metabolomics profiling services to pharma, biotech, and academic clients. It is the most directly comparable scaled competitor to oloBion in the metabolomics services market.
  • Creative Proteomics: Creative Proteomics offers metabolomics, lipidomics, and proteomics services to academic and industry researchers globally. Directly comparable as a multi-omics CRO competing for similar project-based engagements.
  • Biocrates Life Sciences: Biocrates provides standardized metabolomics and lipidomics kits and CRO services focused on quantitative targeted metabolomics. Comparable to oloBion as a specialized metabolomics/lipidomics service provider with proprietary assay panels.
  • Lipotype: Lipotype is a lipidomics-focused CRO providing mass spectrometry-based lipid analysis for academic and industry clients. Directly comparable to oloBion's lipidomics specialization and 4D-ID®-style structural characterization.

Broad incumbents

  • Evotec: Evotec is a global drug discovery CRO with multi-omics, biomarker, and DMPK capabilities. Comparable as a broad incumbent competing for outsourced discovery budgets that oloBion serves in pharma/biotech.
  • Eurofins Discovery: Eurofins Discovery is a large, diversified CRO offering ADME-DMPK, metabolomics, and biomarker services through its Discovery and Pharma Discovery franchises. Comparable to oloBion on ADME-DMPK and analytical services, but with far broader portfolio and scale.
  • Bruker: Bruker is a leading mass spectrometry and NMR instrumentation vendor offering timsTOF-based 4D-omics solutions and increasingly services/applications support. Comparable as a technology incumbent in ion-mobility-based omics that competes at the platform level.
  • Olink (part of Thermo Fisher Scientific): Olink provides proximity extension assay (PEA) proteomics technology and a network of certified service providers. Comparable as the technology incumbent behind the proteomics platform oloBion offers as a Certified Service Provider.
  • Charles River Laboratories: Charles River is a global CRO with discovery, safety assessment, and manufacturing services including preclinical DMPK capabilities. Comparable as a broad incumbent that competes for preclinical ADME-DMPK and discovery budgets.

Regional players

  • West Coast Metabolomics Center (UC Davis): WCMC is an NIH-funded metabolomics core at UC Davis directed by Oliver Fiehn (oloBion's Metabolomics Advisor). It is co-located with oloBion's Davis lab and overlaps in metabolomics services and training offerings.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

oloBion social profiles

Digital presence

oloBion compliance and trust

Trust signal

Compliance3 records

oloBion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

oloBion leadership team

Management profile

Number of profiles

Profiles11 records

oloBion funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

oloBion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about oloBion

What does oloBion do?

oloBion is a science-based Contract Research Organization (CRO) providing end-to-end mass spectrometry-based omics analytical services, including metabolomics, lipidomics, proteomics, ADME-DMPK, ionomics, caroteomics, and nutritional analysis. Sample preparation through biological interpretation is delivered as an integrated service, powered by the proprietary AI-driven oloMAP bioinformatics platform and a database of over one million biomolecules. The company serves academic and industry clients across seven application verticals from its laboratories in Barcelona (Spain) and at UC Davis (USA).

Is oloBion a public or private company?

oloBion is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was oloBion founded?

oloBion was founded in 2020. It employs 11 to 50 people.

Where is oloBion based?

oloBion is headquartered in Barcelona, Spain, in the Europe region.

How does oloBion make money?

Two revenue lines are on record. Omics Analytical Services (CRO) is the primary driver. The others are bioinformatics Software Services (oloMAP Portal).

Who are oloBion's main competitors?

Direct peers on record are Metabolon, Creative Proteomics, Biocrates Life Sciences and Lipotype. Broad incumbents are Evotec, Eurofins Discovery, Bruker, Olink (part of Thermo Fisher Scientific) and Charles River Laboratories. West Coast Metabolomics Center (UC Davis) is listed as a regional player.

Does oloBion have an API?

No public API is recorded for oloBion.

What industry is oloBion in?

oloBion's product category is Contract Research Organization (Omics Analytical Services). Its primary akta.pro industry code is HLAGANAG, Metabolomics & Lipidomics Services. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales